Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Feb 28 04:00PM ET
0.1516
Dollar change
0.0000
Percentage change
0.00
%
Index- P/E- EPS (ttm)-1.40 Insider Own12.96% Shs Outstand37.31M Perf Week1.47%
Market Cap5.66M Forward P/E- EPS next Y-0.41 Insider Trans3.20% Shs Float32.47M Perf Month0.07%
Income-10.44M PEG- EPS next Q-0.10 Inst Own3.32% Short Float1.04% Perf Quarter-18.49%
Sales0.00M P/S- EPS this Y40.18% Inst Trans5.19% Short Ratio0.05 Perf Half Y-82.22%
Book/sh-0.41 P/B- EPS next Y57.95% ROA-1939.09% Short Interest0.34M Perf Year-86.58%
Cash/sh0.00 P/C35.35 EPS next 5Y- ROE-96.57% 52W Range0.11 - 1.36 Perf YTD-5.84%
Dividend Est.- P/FCF- EPS past 5Y43.30% ROI- 52W High-88.85% Beta-0.25
Dividend TTM- Quick Ratio0.04 Sales past 5Y0.00% Gross Margin- 52W Low34.76% ATR (14)0.02
Dividend Ex-Date- Current Ratio0.04 EPS Y/Y TTM61.79% Oper. Margin0.00% RSI (14)51.12 Volatility9.21% 10.53%
Employees2 Debt/Eq- Sales Y/Y TTM- Profit Margin- Recom1.00 Target Price16.38
Option/ShortNo / Yes LT Debt/Eq- EPS Q/Q114.35% Payout- Rel Volume0.00 Prev Close0.15
Sales Surprise- EPS Surprise123.08% Sales Q/Q- EarningsNov 13 AMC Avg Volume6.64M Price0.15
SMA205.42% SMA50-2.49% SMA200-75.44% Trades Volume0 Change0.00%
Feb-22-24 08:30AM
Jan-16-24 08:40AM
Jan-11-24 08:00AM
Jan-05-24 09:15AM
Jan-04-24 08:30AM
08:30AM Loading…
Jan-02-24 08:30AM
Dec-01-23 08:30AM
Nov-29-23 08:05AM
Nov-13-23 04:05PM
Nov-02-23 03:00PM
Oct-31-23 09:15AM
Sep-05-23 08:30AM
Aug-14-23 04:01PM
Aug-10-23 04:15PM
Aug-01-23 08:30AM
08:30AM Loading…
Jul-27-23 08:30AM
Jul-25-23 08:30AM
May-15-23 04:01PM
May-12-23 08:30AM
Apr-27-23 08:30AM
Apr-17-23 04:01PM
Mar-30-23 04:10PM
04:01PM
Mar-08-23 04:01PM
Mar-02-23 08:00AM
Jan-31-23 01:30PM
01:09PM
Jan-27-23 11:58AM
Nov-10-22 04:10PM
Nov-08-22 12:26PM
08:30AM Loading…
08:30AM
Oct-12-22 10:25AM
Oct-11-22 02:15PM
Oct-06-22 11:00PM
Oct-03-22 08:00AM
Sep-23-22 08:51AM
Sep-22-22 04:25PM
Mar-31-22 07:30AM
Feb-16-22 08:20AM
Feb-15-22 10:00PM
07:05AM
Dec-15-21 02:15PM
12:00PM
Dec-12-21 08:00PM
Nov-29-21 08:00AM
Nov-17-21 09:30AM
Nov-12-21 10:40AM
09:20AM
Nov-09-21 09:30PM
Oct-25-21 07:00AM
Aug-26-21 11:04AM
Jun-21-21 08:04AM
Jun-14-21 08:42AM
07:44AM
07:00AM
Apr-26-21 08:09AM
Apr-23-21 11:36PM
09:43AM
08:41AM
Apr-22-21 10:59AM
Apr-21-21 10:34PM
09:38AM
Apr-19-21 10:09PM
06:26AM
Apr-16-21 11:25PM
Apr-14-21 10:34PM
Apr-13-21 11:30PM
03:09PM
02:30PM
09:33AM
06:30AM
Apr-12-21 01:36AM
Jan-11-21 11:32PM
Jan-06-21 09:23AM
Dec-18-20 08:00AM
08:00AM
Dec-17-20 04:27PM
07:00AM
Nov-13-20 05:28AM
Oct-28-20 07:45PM
Oct-23-20 10:00PM
Oct-14-20 08:58PM
10:10AM
Oct-13-20 01:29PM
Oct-12-20 01:35PM
12:45PM
10:47AM
06:30AM
Sep-09-20 08:00AM
Aug-17-20 10:33AM
Aug-14-20 07:30AM
Aug-04-20 12:53PM
Jul-28-20 05:50PM
Jul-22-20 05:50PM
Jul-21-20 08:30AM
Jul-16-20 05:50PM
Jul-09-20 05:50PM
11:30AM
Jul-07-20 11:50AM
Jun-29-20 08:30AM
Avenue Therapeutics, Inc. is a specialty pharmaceutical company, which engages in acquiring, licensing, and commercializing products for use in the intensive care hospital setting. It focuses on the development of intravenous tramadol, a potential alternative that could reduce the use of conventional opioids for patients suffering from acute pain. The company was founded on February 9, 2015 and is headquartered in Bay Harbor Islands, FL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Davidow Robert L10% OwnerDec 11Sale0.14353,00049,60022,000Dec 13 04:02 PM
Davidow Robert L10% OwnerDec 11Sale0.14264,00036,960681,000Dec 13 04:02 PM
Fortress Biotech, Inc.10% OwnerSep 08Buy0.72418,410301,2551,032,390Sep 12 09:02 AM
ROSENWALD LINDSAY A MDDirectorSep 08Buy0.72348,675251,046354,318Sep 12 09:03 AM